| Clinical data | |
|---|---|
| Other names | EDB; Estradiol 3,17β-dibenzoate; Estra-1,3,5(10)-triene-3,17β-diol 3,17β-dibenzoate |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C32H32O4 |
| Molar mass | 480.604 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Estradiol dibenzoate (EDB), also known asestradiol 3,17β-dibenzoate, is anestrogen ester which was developed in the 1930s and was never marketed.[1][2][3][4][5][6][7] It is the C3 and C17βbenzoatediester ofestradiol.[1] Estradiol dibenzoate has a longerduration of action thanestradiol benzoate (estradiol 3-benzoate) bydepot injection.[2][3][4][5][6][7]
{{cite book}}:ISBN / Date incompatibility (help)Thisdrug article relating to thegenito-urinary system is astub. You can help Wikipedia byexpanding it. |